Clinical success was obtained in 88%, in which 11% patients were cured and 67% patients were improved, and 11% patients failed to respond to PTRA.
Tỷ lệ thành công về mặt lâm sàng 88% gồm lành bệnh 11%, cải thiện bệnh 67%, thất bại 22%.